Advisor Group Holdings, Inc. Trevena Inc Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$1.53 - $3.13 $3,696 - $7,562
-2,416 Reduced 10.73%
20,100 $60,000
Q2 2020

Aug 14, 2020
BUY
$0.48 - $1.75 $3,607 - $13,153
7,516 Added 50.11%
22,516 $34,000
Q1 2020

May 18, 2020
BUY
$0.56 - $0.97 $8,400 - $14,550
15,000 New
15,000 $9,000

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $313M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email